APA (7th ed.) Citation

Park, J., Cheon, J. H., Lee, K., Kim, Y., Ye, B. D., Eun, C. S., . . . Schreiber, S. (2023, May). Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, between CT-P13 and Originator Infliximab. Gut and Liver.

Chicago Style (17th ed.) Citation

Park, Jihye, et al. "Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, Between CT-P13 and Originator Infliximab." Gut and Liver May. 2023.

MLA (9th ed.) Citation

Park, Jihye, et al. "Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, Between CT-P13 and Originator Infliximab." Gut and Liver, May. 2023.